Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › MEDFORD › HALLMARK HEALTH

HALLMARK HEALTH

NPI: 1700926169 · MEDFORD, MA 02155 · Rehabilitation Hospital Unit · NPI assigned 02/07/2007

$902K
Total Medicaid Paid
17,829
Total Claims
16,762
Beneficiaries
90
Codes Billed
2019-04
First Month
2020-05
Last Month

Provider Details

Authorized OfficialWHIPPLE, CHARLES (GENERAL COUNSEL)
NPI Enumeration Date02/07/2007

Related Entities

Other providers sharing the same authorized official: WHIPPLE, CHARLES

ProviderCityStateTotal Paid
HALLMARK HEALTH SYSTEM INC MEDFORD MA $1.79M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 12,462 $653K
2020 5,367 $249K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 883 845 $164K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 569 540 $125K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 713 659 $116K
99284 Emergency department visit for the evaluation and management, high severity 477 465 $97K
96361 Intravenous infusion, hydration; each additional hour 107 104 $54K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 236 231 $33K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 185 174 $32K
99282 Emergency department visit for the evaluation and management, low to moderate severity 162 161 $30K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 127 127 $21K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 461 456 $17K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 314 282 $16K
59025 Fetal non-stress test 64 32 $15K
99281 Emergency department visit for the evaluation and management, self-limited or minor 72 71 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 445 440 $13K
80053 Comprehensive metabolic panel 1,016 919 $11K
76830 Ultrasound, transvaginal 68 68 $10K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,257 1,123 $9K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 105 103 $8K
77063 Screening digital breast tomosynthesis, bilateral 59 59 $8K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 189 188 $7K
70450 Computed tomography, head or brain; without contrast material 54 52 $7K
71046 Radiologic examination, chest; 2 views 488 475 $6K
84443 Thyroid stimulating hormone (TSH) 376 369 $6K
87086 Culture, bacterial; quantitative colony count, urine 664 604 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 146 146 $5K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 30 25 $4K
84702 274 228 $4K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 144 142 $4K
83036 Hemoglobin; glycosylated (A1C) 231 229 $3K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 13 13 $3K
83735 438 395 $3K
87070 339 325 $3K
84484 231 190 $3K
87480 92 90 $3K
87081 348 342 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 68 67 $2K
80048 Basic metabolic panel (calcium, ionized) 178 165 $2K
85027 326 320 $2K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 25 25 $2K
80061 Lipid panel 289 289 $2K
86592 75 75 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 153 151 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 14 12 $2K
87510 92 90 $2K
81001 549 517 $2K
87660 92 90 $2K
81025 226 220 $1K
82553 119 106 $1K
80074 49 49 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 23 21 $1K
73630 62 61 $1K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 448 403 $1K
87205 233 224 $1K
83690 151 145 $985.00
86850 65 62 $964.19
80076 168 160 $789.64
82728 50 50 $772.66
87186 93 92 $724.64
84439 80 79 $675.29
82150 96 93 $639.47
73610 30 30 $604.87
73562 26 26 $604.87
81003 265 258 $568.22
83655 28 28 $563.56
82948 92 77 $482.01
87400 18 18 $393.84
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 13 13 $346.60
87147 45 44 $324.24
83540 40 40 $277.81
86900 79 76 $274.47
86901 79 76 $226.94
73110 13 13 $201.63
82550 243 201 $182.29
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 12 12 $156.80
85652 53 51 $152.54
77067 Screening mammography, bilateral, including computer-aided detection 60 60 $138.00
85610 30 25 $115.43
83550 14 14 $103.61
J2405 Injection, ondansetron hydrochloride, per 1 mg 169 136 $47.30
J1885 Injection, ketorolac tromethamine, per 15 mg 182 172 $47.30
82947 16 15 $25.06
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 72 72 $0.00
84460 12 12 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 115 106 $0.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 344 327 $0.00
80320 275 242 $0.00
36415 Collection of venous blood by venipuncture 257 243 $0.00
96375 Therapeutic injection; each additional sequential IV push 114 111 $0.00
J2704 Injection, propofol, 10 mg 15 14 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 17 12 $0.00